Open AccessExperience with hemoadsorption (CytoSorb®) in the management of septic shock patients
Author(s) -
Yatin Mehta,
Chitra Mehta,
Ashish Kumar,
Joby V. George,
Aditi Gupta,
Saurabh Nanda,
Gourav Kochhar,
Arun Raizada
Publication year - 2020
Publication title -
world journal of critical care medicine
Language(s) - English
Resource type - Journals
ISSN - 2220-3141
DOI - 10.5492/wjccm.v9.i1.1
Subject(s) - medicine , procalcitonin , septic shock , sepsis , cytokine storm , intensive care unit , interleukin 6 , cytokine , shock (circulatory) , gastroenterology , anesthesia , disease , covid-19 , infectious disease (medical specialty)
Cytokines and inflammatory mediators are the hallmarks of sepsis. Extracorporeal cytokine hemoadsorption devices are the newer clinical support system to overcome the cytokine storm during sepsis.